Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gliatech
AddedMar 20, 2024
UpdatedJun 18, 2026
Gliatech

Gliatech

Closed

Discovering medical solutions from glial cells for CNS disorders.

HQ
Cleveland, OH, US
Founded
1988
Overview
Compare
Fundraising
Employees

Gliatech Inc., founded in 1988, focuses on discovering, developing, and commercializing therapeutic products based on the properties of glial cells, which are crucial for CNS function. The company offers ADCON® gels and solutions, medical devices designed to inhibit postsurgical scarring and adhesions.

Gliatech's innovative approach has made significant strides in medical device development, particularly in CNS-related therapies. The company's ADCON® products have gained recognition for their effectiveness in reducing surgical complications, contributing to improved patient outcomes.

Gliatech - Similar Companies

Gliacure logo

Gliacure

BrainCells logo

BrainCells

Glaukos logo

Glaukos

glaukos.com

Neurolink logo

Neurolink

Gate Neurosciences logo

Gate Neurosciences

gateneuro.com

Great Lakes NeuroTechnologies logo

Great Lakes NeuroTechnologies

glneurotech.com

Adenios logo

Adenios

G-Tech Medical logo

G-Tech Medical

gtechmedical.com

NeuraMedica logo

NeuraMedica

BioCircuit Technologies logo

BioCircuit Technologies

biocircuit.com

Gliknik logo

Gliknik

gliknik.com

GT Medical Technologies logo

GT Medical Technologies

gtmedtech.com

Thompson SCI logo

Thompson SCI

Cordance Medical logo

Cordance Medical

AsparaGlue logo

AsparaGlue

Gliatech - Quick Facts

Who are Gliatech's competitors?

Companies similar to Gliatech include Gliacure, BrainCells, Glaukos and Neurolink.

When was Gliatech founded?

Gliatech was founded in 1988.

Where is Gliatech's headquarters located?

Gliatech's headquarters is located in Cleveland, OH, US.

When was Gliatech's last funding round?

Gliatech's most recent funding round was for $2.5M (USD) in June 2001.

How much has Gliatech raised to-date?

As of Jun 27, 2001, Gliatech has raised a total of $2.5M (USD).

Gliatech - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 8 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 7210Research and experimental development on natural sciences and engineering